Related Experiment Video
Updated: Feb 14, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
RETRACTED: MicroRNA-19a and microRNA-19b promote the malignancy of clear cell renal cell carcinoma through targeting
Shaoxi Niu1,2, Xin Ma1, Yu Zhang1
1Department of Urology/State Key Laboratory of Kidney Diseases, Chinese PLA General Hospital/Chinese PLA Medical Academy, Beijing, People's Republic of China.
Abstract:
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell carcinoma, which shows high aggressiveness and lacks biomarkers. RhoB acts as a tumor suppressor that inhibits the progression of ccRCC. In the present study, we examined the effects of oncogenic microRNAs, miR-19a and miR-19b, on RhoB expression in ccRCC cells. The results showed that both miR-19a and miR-19b could directly target the 3'untranslated region (3'UTR) of RhoB, resulting in the reduced expression of RhoB. With RT-PCR analysis, we detected the increased expression of miR-19a and miR-19b in ccRCC tissues compared to adjacent non-tumor renal tissues. These data also demonstrated an exclusive negative correlation between miR-19a/19b and RhoB expression in ccRCC specimens and cell lines. In addition, the knockdown of RhoB or overexpression of miR-19a and miR-19b in ccRCC cells could promote cell proliferation, migration and invasion. These data demonstrate the direct roles of miR-19a and miR-19b on the repression of RhoB and its consequences on tumorigenesis, cancer cell proliferation and invasiveness. These results suggest the potential clinical impact of miR-19a and miR-19b as molecular targets for ccRCC.
Insights
Oncogenic miR-19a and miR-19b directly suppress the tumor suppressor RhoB in clear cell renal cell carcinoma (ccRCC). This leads to increased ccRCC cell proliferation and invasion, suggesting miR-19a/19b as potential therapeutic targets.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Clear cell renal cell carcinoma (ccRCC) is an aggressive kidney cancer subtype lacking effective biomarkers.
- RhoB functions as a tumor suppressor, inhibiting ccRCC progression.
- Identifying regulatory mechanisms controlling RhoB is crucial for ccRCC treatment.
Purpose of the Study:
- To investigate the role of microRNAs (miRNAs), specifically miR-19a and miR-19b, in regulating RhoB expression in ccRCC.
- To determine the impact of miR-19a and miR-19b on ccRCC cell behavior.
Main Methods:
- Reverse Transcription Polymerase Chain Reaction (RT-PCR) was used to analyze miR-19a and miR-19b expression levels.
- Luciferase reporter assays were performed to confirm direct targeting of RhoB's 3' untranslated region (3'UTR) by miR-19a/19b.
- Functional assays assessed the effects of RhoB knockdown or miR-19a/19b overexpression on ccRCC cell proliferation, migration, and invasion.
Main Results:
- miR-19a and miR-19b were found to be upregulated in ccRCC tissues compared to adjacent non-tumor tissues.
- Both miRNAs directly target and reduce RhoB expression by binding to its 3'UTR.
- A negative correlation was observed between miR-19a/19b levels and RhoB expression in ccRCC.
- Overexpression of miR-19a/19b or knockdown of RhoB promoted ccRCC cell proliferation, migration, and invasion.
Conclusions:
- miR-19a and miR-19b play a significant role in repressing RhoB expression in ccRCC.
- The downregulation of RhoB by these miRNAs contributes to ccRCC tumorigenesis and aggressiveness.
- miR-19a and miR-19b represent potential molecular targets for novel ccRCC therapies.
Related Concept Videos
MicroRNAs
MicroRNAs
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Clot Retraction and Fibrinolysis
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

